CHIH


MSCI China Health Care ETF

Reasons to Consider CHIH

Targeted Exposure

CHIH is a targeted play on the Health Care Sector in China – the world’s second largest economy by GDP.

ETF Efficiency

In a single trade, CHIH delivers access to dozens of health care companies within the MSCI China Index, providing investors an efficient vehicle to express a sector view on China.

All Share Exposure

The Index incorporates all eligible securities as per MSCI’s Global Investable Market Index Methodology, including China A, B and H shares, Red chips, P chips and foreign listings, among others.

Key Information As of 03/23/23

Inception Date 12/07/18
Total Expense Ratio 0.65%
Net Assets $9.77 million
NAV $16.29
Fact Sheet

ETF Summary

The Global X MSCI China Health Care ETF (CHIH) seeks to invest in large- and mid-capitalization segments of the MSCI China Index that are classified in the Health Care Sector as per the Global Industry Classification System (GICS).

ETF Objective

The Global X MSCI China Health Care ETF (CHIH) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI China Health Care 10/50 Index.

Trading Details As of 03/23/23

Ticker CHIH
Bloomberg Index Ticker NU722071
CUSIP 37954Y541
ISIN US37954Y5419
Primary Exchange NYSE Arca
Shares Outstanding 600,002
Number of Holdings 81
30-Day Median Bid-Ask Spread 1.34%

Distributions As of 03/23/23

30-Day SEC Yield 0.37%
Distribution Frequency Semi-Annually

ETF Prices As of 03/23/23

NAV $16.29 Daily Change -$0.02 -0.12%
Market Price $16.12 Daily Change -$0.07 -0.43%

Performance History

As of recent
(12/31/22)
As of recent
(12/31/22)
Fund NAV Market Price Index
1 Year -22.67% -23.41% -22.12%
3 Years -1.61% -1.99% -0.91%
Since Inception 3.03% 2.74% 3.78%
1 Year -10.75% -11.37% -10.11%
3 Years -3.65% -3.87% -2.96%
Since Inception 2.79% 2.66% 3.54%
Year-to-Date -22.67% -23.41% -22.12%
1 Month 4.39% 1.62% 4.43%
3 Months 25.30% 24.81% 25.66%
Since Inception 12.90% 11.61% 16.29%
Year-to-Date -0.48% 0.12% -0.37%
1 Month -8.67% -9.46% -8.61%
3 Months 3.89% 1.75% 4.04%
Since Inception 12.36% 11.75% 15.86%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings As of 03/23/23

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
8.56 6160 HK BEIGENE LTD BGDY260 16.98 49,239 836,154.08
8.39 2269 HK WUXI BIOLOGICS CAYMAN INC BL6B9P1 6.46 126,880 819,498.32
6.91 1093 HK CSPC PHARMACEUTI 6191997 0.99 684,808 675,237.77
4.89 1177 HK SINO BIOPHARMACEUTICAL B00XSF9 0.56 848,300 477,659.78
4.44 1801 HK INNOVENT BIOLOGICS INC BGR6KX5 4.97 87,400 434,233.16
3.34 1099 HK SINOPHARM GROUP CO-H B3ZVDV0 2.89 112,900 326,487.64
3.28 1066 HK SHANDONG WEIG-H 6742340 1.55 207,300 320,601.04
3.11 2359 HK WUXI APPTEC CO LTD-H BGHH0L6 10.45 29,056 303,526.50
2.82 300760 C2 SHENZHEN MINDR-A BHQK864 45.75 6,017 275,293.87
2.49 1548 HK GENSCRIPT BIOTECH CORP BD9Q2J2 2.45 99,471 243,301.43
2.35 ZLAB ZAI LAB LTD-ADR BD9GVY0 31.46 7,306 229,846.76
2.20 6078 HK HYGEIA HEALTHCAR BMX09H0 7.50 28,600 214,599.28
2.15 600276 C1 JIANGSU HENGRU-A BP3R369 6.26 33,572 210,149.74
1.95 867 HK CHINA MEDICAL SY B6WY993 1.58 119,900 190,014.40
1.93 3692 HK HANSOH PHARMACEU BJYKB72 1.79 105,300 188,339.94
1.83 LEGN LEGEND BIOTECH CORP-ADR BMX9K07 43.82 4,080 178,785.60
1.80 300015 C2 AIER EYE HSPTL-A BD5CLQ4 4.50 39,048 175,859.64
1.64 603259 C1 WUXI APPTEC CO LTD-A BHWLWV4 11.78 13,624 160,450.47
1.55 853 HK MICROPORT SCIENTIFIC CORP B676TW7 2.61 58,100 151,361.84
1.54 9926 HK AKESO INC - B BLFJ7Y1 5.37 28,000 150,349.69
1.47 2607 HK SHANGHAI PHARM-H B4Q4CJ6 1.92 74,700 143,315.29
1.45 600436 C1 ZHANGZHOU PIEN-A BP3R7Z6 41.56 3,406 141,553.37
1.43 570 HK TRAD CHI MED 6971779 0.54 260,600 139,434.63
1.39 1530 HK 3SBIO INC BY9D3L9 1.00 136,700 136,182.78
1.37 2196 HK FOSUN PHARMA-H B8XBQ96 2.82 47,300 133,469.43
1.24 3320 HK CHINA RESOURCES BYNGG26 0.89 136,500 121,028.83
1.15 3347 HK HANGZHOU TIGER-H BMZC7F8 10.48 10,720 112,393.59
1.13 300122 C2 CHONGQING ZHIF-A BD5CJY8 12.67 8,733 110,625.39
0.94 3759 HK PHARMARON BEIJ-H BK72QD3 5.24 17,575 92,020.40
0.91 000538 C2 YUNNAN BAIYAO-A BD5CP95 7.89 11,314 89,228.67
0.89 300896 C2 IMEIK TECHNOLO-A BNR4MY3 75.51 1,156 87,286.98
0.76 000963 C2 HUADONG MEDICINE CO LTD-A BD5CM94 6.37 11,611 73,975.59
0.66 600196 C1 SHANGHAI FOSUN-A BP3R3M5 4.71 13,574 63,960.58
0.60 600085 C1 BEIJING TONGRENTANG CO-A BP3R5C9 7.44 7,900 58,803.96
0.60 603392 C1 BEIJING WANTAI-A BMXTWX4 17.68 3,290 58,158.33
0.58 600332 C1 GUANGZHOU BAIY-A BP3R4Q6 4.65 12,159 56,508.27
0.58 000661 C2 CHANGCHUN HIGH-A BD5CDB3 24.59 2,290 56,313.98
0.54 002294 C2 SHENZHEN SALUBRIS PHARM-A BD5CM05 5.19 10,200 52,910.45
0.53 300142 C2 WALVAX BIOTECHNOLOGY CO-A BD5CG36 5.37 9,700 52,095.53
0.52 002001 C2 ZHEJIANG NHU CO LTD-A BD5CH66 2.61 19,568 51,010.89
0.52 601607 C1 SHANG PHARM -A BP3R4Z5 3.02 16,700 50,369.61
0.51 300347 C2 HANGZHOU TIGER-A BD5CCK5 15.59 3,216 50,146.13
0.51 002422 C2 SICHUAN KELUN-A BD5CL08 3.97 12,500 49,657.82
0.49 300759 C2 PHARMARON BEIJ-A BK4XYC4 8.56 5,600 47,910.92
0.47 002603 C2 SHIJIAZHUANG Y-A BD5CHJ9 4.20 11,027 46,329.69
0.47 000999 C2 CHINA RESOURCE-A BD5CL42 7.88 5,800 45,725.10
0.47 000423 C2 DONG-E-E-JIAOCO LTD-A BD5CM61 6.71 6,800 45,598.35
0.46 600998 C1 JOINTOWN PHARMACEUTICAL-A BP3R541 2.18 20,770 45,247.23
0.43 300832 C2 SHENZHEN NEW-A BMXTX20 8.34 5,000 41,692.03
0.42 002821 C2 ASYMCHEM LABOR-A BD6V5C4 20.29 2,038 41,357.05
0.42 600079 C1 HUMANWELL HEAL-A BP3R712 3.81 10,700 40,733.35
0.41 002044 C2 MEINIAN ONEHEA-A BD73L10 0.98 41,020 40,017.16
0.41 002252 C2 SHANGHAI RAAS -A BD5CPJ5 0.92 43,400 39,855.94
0.41 300003 C2 LEPU MEDICAL TECHNOLOGY-A BD5CM16 3.45 11,501 39,649.02
0.40 603882 C1 GUANGZHOU KING-A BFYX689 12.60 3,100 39,069.19
0.39 002007 C2 HUALAN BIOLOGI-A BD5CL19 3.29 11,670 38,382.70
0.39 600763 C1 TOPCHOICE MEDI-A BYYFJH8 19.36 1,980 38,341.41
0.37 603858 C1 SHANDONG BUCHA-A BYW5NC3 2.90 12,587 36,468.54
0.35 688363 C1 BLOOMAGE BIOTE-A BP91NT8 16.16 2,097 33,888.42
0.34 688180 C1 SHANGHAI JUNSH-A BLCD7F7 7.21 4,642 33,490.58
0.34 300601 C2 SHENZHEN KANGT-A BFY8HT2 4.75 7,048 33,458.26
0.32 603456 C1 ZHEJIANG JIUZH-A BMQBVL8 5.47 5,700 31,173.08
0.31 300595 C2 OVCTEK CHINA INC-A BHQPSJ2 4.82 6,224 29,984.84
0.30 600521 C1 ZHEJIANG HUAHA-A BP3RBR6 2.91 10,010 29,134.31
0.30 002223 C2 JIANGSU YUYUE-A BD5CJM6 4.46 6,500 28,997.38
0.29 000739 C2 APELOA PHARMA-A BD5LY17 3.28 8,500 27,894.20
0.28 300357 C2 ZHEJIANG WOLWO-A BFY8GY0 7.32 3,723 27,242.60
0.27 300676 C2 BGI GENOMICS CO LTD-A BFY8H58 8.72 3,033 26,460.58
0.27 603707 C1 NANJING KING-F-A BF2DZL7 2.33 11,236 26,224.72
0.27 300529 C2 JAFRON BIOMEDI-A BFY8H03 4.48 5,800 25,993.71
0.27 600380 C1 JOINCARE PHARM-A BP3RBV0 1.88 13,800 25,913.02
0.26 600566 C1 HUBEI JUMPCAN -A BS7K3N2 4.17 6,200 25,830.87
0.26 300558 C2 BETTA PHARMACE-A BD6QWL7 8.19 3,120 25,548.97
0.26 688301 C1 IRAY TECHNOLOGY CO LTD-A BQ3RXC2 52.83 482 25,463.80
0.25 300363 C2 PORTON PHARMA -A BD5LZ92 6.16 4,000 24,639.67
0.25 603127 C1 JOINN LABORATO-A BK94819 7.97 3,040 24,229.38
0.25 000513 C2 LIVZON PHARM-A BD5CQ25 5.11 4,700 24,001.09
0.24 002030 C2 DAAN GENE CO LTD-A BD5CKW3 2.31 10,160 23,445.06
0.23 600056 C1 CHINA MEHECO CO LTD -A BP3R8X1 2.07 11,000 22,817.66
0.13 688202 C1 SHANGHAI MEDICILON INC-A BNR4NV7 24.00 547 13,125.62
0.10 603658 C1 AUTOBIO DIAGNO-A BYW5N89 8.68 1,100 9,553.08
0.04 CASH 1.00 4,127 4,127.41
0.00 HONG KONG DOLLAR 0.00 0 0.00
0.00 CHINESE YUAN RENMINBI 0.15 -1 -0.09
Holdings are subject to change. "Cash" denotes U.S. dollars.

ETF Characteristics As of 03/23/23

Return on Equity 9.70%
Weighted Avg. Market Cap 14,032 M
2022 2023
Price-to-earnings 42.58 28.60
Price-to-book value 2.87 2.68

Source: AltaVista Research, LLC

ETF Risk Stats As of 02/28/23

Versus Beta
S&P 500 0.52
MSCI EAFE 0.69
MSCI Emg. Mkts 0.98
Standard Deviation 32.00%

Source: AltaVista Research, LLC

ETF Research

View More Related Research

Investing involves risk, including the possible loss of principal. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles, or from economic or political instability in other nations. Emerging markets involve heightened risks related to the same factors as well as increased volatility and lower trading volume. Securities focusing on a single country and narrowly focused investments may be subject to higher volatility. CHIH is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Since the Fund’s shares did not trade in the secondary market until several days after the Fund’s inception, for the period from inception to the first day of secondary market trading in Shares, the NAV of the Fund is used to calculate market returns.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by MSCI, nor does MSCI make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with MSCI.

Back to Top